Searchable abstracts of presentations at key conferences in endocrinology

ea0012p126 | Thyroid | SFE2006

Identifying risk factors for relapse in Graves’ disease: a retrospective study

Jivanjee A , Martin NM , Meeran K

GravesÂ’ disease typically follows a relapsing and remitting course. Most patients with recurrent hyperthyroidism after withdrawal of antithyroid drugs (ATDs) are offered definitive treatment with radioactive iodine. This retrospective study aimed to identify clinical and biochemical indices that predict relapse following ATD withdrawal, which could allow earlier definitive treatment to be initiated.We studied 70 patients with GravesÂ’ disease wh...